These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1446 related articles for article (PubMed ID: 33739254)

  • 1. Case fatality risk of the SARS-CoV-2 variant of concern B.1.1.7 in England, 16 November to 5 February.
    Grint DJ; Wing K; Williamson E; McDonald HI; Bhaskaran K; Evans D; Evans SJ; Walker AJ; Hickman G; Nightingale E; Schultze A; Rentsch CT; Bates C; Cockburn J; Curtis HJ; Morton CE; Bacon S; Davy S; Wong AY; Mehrkar A; Tomlinson L; Douglas IJ; Mathur R; Blomquist P; MacKenna B; Ingelsby P; Croker R; Parry J; Hester F; Harper S; DeVito NJ; Hulme W; Tazare J; Goldacre B; Smeeth L; Eggo RM
    Euro Surveill; 2021 Mar; 26(11):. PubMed ID: 33739254
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Risk of hospital admission for patients with SARS-CoV-2 variant B.1.1.7: cohort analysis.
    Nyberg T; Twohig KA; Harris RJ; Seaman SR; Flannagan J; Allen H; Charlett A; De Angelis D; Dabrera G; Presanis AM
    BMJ; 2021 Jun; 373():n1412. PubMed ID: 34130987
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mortality and critical care unit admission associated with the SARS-CoV-2 lineage B.1.1.7 in England: an observational cohort study.
    Patone M; Thomas K; Hatch R; Tan PS; Coupland C; Liao W; Mouncey P; Harrison D; Rowan K; Horby P; Watkinson P; Hippisley-Cox J
    Lancet Infect Dis; 2021 Nov; 21(11):1518-1528. PubMed ID: 34171232
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Increased mortality in community-tested cases of SARS-CoV-2 lineage B.1.1.7.
    Davies NG; Jarvis CI; ; Edmunds WJ; Jewell NP; Diaz-Ordaz K; Keogh RH
    Nature; 2021 May; 593(7858):270-274. PubMed ID: 33723411
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Risk of mortality in patients infected with SARS-CoV-2 variant of concern 202012/1: matched cohort study.
    Challen R; Brooks-Pollock E; Read JM; Dyson L; Tsaneva-Atanasova K; Danon L
    BMJ; 2021 Mar; 372():n579. PubMed ID: 33687922
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of the relative virulence of novel SARS-CoV-2 variants: a retrospective cohort study in Ontario, Canada.
    Fisman DN; Tuite AR
    CMAJ; 2021 Oct; 193(42):E1619-E1625. PubMed ID: 34610919
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High throughput diagnostics and dynamic risk assessment of SARS-CoV-2 variants of concern.
    Gravagnuolo AM; Faqih L; Cronshaw C; Wynn J; Klapper P; Wigglesworth M
    EBioMedicine; 2021 Aug; 70():103540. PubMed ID: 34392145
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of the Coronavirus Disease 2019 (COVID-19) Pandemic on Invasive Pneumococcal Disease and Risk of Pneumococcal Coinfection With Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2): Prospective National Cohort Study, England.
    Amin-Chowdhury Z; Aiano F; Mensah A; Sheppard CL; Litt D; Fry NK; Andrews N; Ramsay ME; Ladhani SN
    Clin Infect Dis; 2021 Mar; 72(5):e65-e75. PubMed ID: 33196783
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Growth, reproduction numbers and factors affecting the spread of SARS-CoV-2 novel variants of concern in the UK from October 2020 to July 2021: a modelling analysis.
    Ward T; Glaser A; Johnsen A; Xu F; Hall I; Pellis L
    BMJ Open; 2021 Nov; 11(11):e056636. PubMed ID: 34819293
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The COVID-19 pandemic in the WHO African region: the first year (February 2020 to February 2021).
    Impouma B; Mboussou F; Farham B; Wolfe CM; Johnson K; Clary C; Mihigo R; Nsenga N; Talisuna A; Yoti Z; Flahault A; Keiser O; Gueye AS; Cabore J; Moeti M
    Epidemiol Infect; 2021 Nov; 149():e263. PubMed ID: 34732270
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Why Does the SARS-CoV-2 Delta VOC Spread So Rapidly? Universal Conditions for the Rapid Spread of Respiratory Viruses, Minimum Viral Loads for Viral Aerosol Generation, Effects of Vaccination on Viral Aerosol Generation, and Viral Aerosol Clouds.
    Lee BU
    Int J Environ Res Public Health; 2021 Sep; 18(18):. PubMed ID: 34574724
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Age-Specific Changes in Virulence Associated With Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Variants of Concern.
    Fisman DN; Tuite AR
    Clin Infect Dis; 2022 Aug; 75(1):e69-e75. PubMed ID: 35234859
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Estimated transmissibility and impact of SARS-CoV-2 lineage B.1.1.7 in England.
    Davies NG; Abbott S; Barnard RC; Jarvis CI; Kucharski AJ; Munday JD; Pearson CAB; Russell TW; Tully DC; Washburne AD; Wenseleers T; Gimma A; Waites W; Wong KLM; van Zandvoort K; Silverman JD; ; ; Diaz-Ordaz K; Keogh R; Eggo RM; Funk S; Jit M; Atkins KE; Edmunds WJ
    Science; 2021 Apr; 372(6538):. PubMed ID: 33658326
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Assessing transmissibility of SARS-CoV-2 lineage B.1.1.7 in England.
    Volz E; Mishra S; Chand M; Barrett JC; Johnson R; Geidelberg L; Hinsley WR; Laydon DJ; Dabrera G; O'Toole Á; Amato R; Ragonnet-Cronin M; Harrison I; Jackson B; Ariani CV; Boyd O; Loman NJ; McCrone JT; Gonçalves S; Jorgensen D; Myers R; Hill V; Jackson DK; Gaythorpe K; Groves N; Sillitoe J; Kwiatkowski DP; ; Flaxman S; Ratmann O; Bhatt S; Hopkins S; Gandy A; Rambaut A; Ferguson NM
    Nature; 2021 May; 593(7858):266-269. PubMed ID: 33767447
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Update on SARS-CoV-2 Omicron Variant of Concern and Its Peculiar Mutational Profile.
    Alkhatib M; Salpini R; Carioti L; Ambrosio FA; D'Anna S; Duca L; Costa G; Bellocchi MC; Piermatteo L; Artese A; Santoro MM; Alcaro S; Svicher V; Ceccherini-Silberstein F
    Microbiol Spectr; 2022 Apr; 10(2):e0273221. PubMed ID: 35352942
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Omicron: What Makes the Latest SARS-CoV-2 Variant of Concern So Concerning?
    Jung C; Kmiec D; Koepke L; Zech F; Jacob T; Sparrer KMJ; Kirchhoff F
    J Virol; 2022 Mar; 96(6):e0207721. PubMed ID: 35225672
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Changes in the associations of race and rurality with SARS-CoV-2 infection, mortality, and case fatality in the United States from February 2020 to March 2021: A population-based cohort study.
    Ioannou GN; Ferguson JM; O'Hare AM; Bohnert ASB; Backus LI; Boyko EJ; Osborne TF; Maciejewski ML; Bowling CB; Hynes DM; Iwashyna TJ; Saysana M; Green P; Berry K
    PLoS Med; 2021 Oct; 18(10):e1003807. PubMed ID: 34673772
    [TBL] [Abstract][Full Text] [Related]  

  • 18. SARS-CoV-2 Variant of Concern 202012/01 Has about Twofold Replicative Advantage and Acquires Concerning Mutations.
    Grabowski F; Preibisch G; Giziński S; Kochańczyk M; Lipniacki T
    Viruses; 2021 Mar; 13(3):. PubMed ID: 33804556
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Estimation of SARS-CoV-2 mortality during the early stages of an epidemic: A modeling study in Hubei, China, and six regions in Europe.
    Hauser A; Counotte MJ; Margossian CC; Konstantinoudis G; Low N; Althaus CL; Riou J
    PLoS Med; 2020 Jul; 17(7):e1003189. PubMed ID: 32722715
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Editorial: World Health Organization (WHO) Variants of Concern Lineages Under Monitoring (VOC-LUM) in Response to the Global Spread of Lineages and Sublineages of Omicron, or B.1.1.529, SARS-CoV-2.
    Parums DV
    Med Sci Monit; 2022 Jul; 28():e937676. PubMed ID: 35775166
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 73.